| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/18/2009 | CN101366939A Compound traditional Chinese medicine Xintongling nano-microcapsule and preparation thereof |
| 02/18/2009 | CN101366918A Preparation method of medicinal granules for clearing fat, reducing blood pressure and pacifying the mind |
| 02/18/2009 | CN101366916A Chinese medicinal composition of embolism extinguishing medicinal granules |
| 02/18/2009 | CN101366910A Traditional Chinese medicine for treating frequent premature beat |
| 02/18/2009 | CN101366902A Traditional Chinese medicine for treating high blood pressure |
| 02/18/2009 | CN101366830A Tartary buckwheat biological flavone effervescent tablet and preparation method thereof |
| 02/18/2009 | CN101366787A Medicine for treating hemorrhoids |
| 02/18/2009 | CN101366738A Application of ilex pubescens total flavone in preparing medicament for preventing and controlling transient ischemic attack syndrome |
| 02/18/2009 | CN101366736A Green alga abstraction composition for reducing hyperpiesis and preparation |
| 02/18/2009 | CN101366517A Nourishing gruel for diabetes patients |
| 02/18/2009 | CN101366511A Medicinal food prescription for preventing hyperpiesis for persons in middle and old age |
| 02/18/2009 | CN101366503A Supercritical CO2 abstraction method for tartary buckwheat bran oil |
| 02/18/2009 | CN101366442A Sheep hemoglobin blood pressure reduction peptide and preparation method |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462351C Amino acids with affinity for the alpha-2-delta-protein |
| 02/18/2009 | CN100462085C Medicament or health food tablet for regulating blood sugar, blood pressure and blood lipid and their making method |
| 02/18/2009 | CN100462082C Erigeron breviscapus ketone ester and its injection preparation process |
| 02/18/2009 | CN100462081C Preparing method for intermediate of perennial sowthistle |
| 02/18/2009 | CN100462077C Perhexiline injection and its preparing method |
| 02/18/2009 | CN100462072C Medicine composition used for injection and its preparing method |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491815 Antisense modulation of C-reactive protein expression |
| 02/17/2009 | US7491796 Retro-inversion peptides that target GIT receptors and related methods |
| 02/17/2009 | US7491747 4-(Arylthio)- or (4-heteroarylthio)butyric acid derivatives that may be used in the treatment of dyslipidaemia, atherosclerosis and diabetes |
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491740 Isoxazoline compounds having MIF antagonist activity |
| 02/17/2009 | US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease |
| 02/17/2009 | US7491733 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 02/17/2009 | US7491730 Compositions useful as inhibitors of GSK-3 |
| 02/17/2009 | US7491693 Administering High Density Lipoproteins |
| 02/17/2009 | US7491550 Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) |
| 02/17/2009 | US7491507 Using lactobacillus to ferment hypotensive agents comprised of milk protein amino acid sequences; treatment for hypertension |
| 02/17/2009 | US7491389 Bone marrow; controlling cell differentiation |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/17/2009 | CA2428315C Indole and dihydroindole derivatives |
| 02/17/2009 | CA2400217C Pteridine compounds for the treatment of psoriasis |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/17/2009 | CA2348380C Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 02/17/2009 | CA2217054C Compositions and methods for inhibiting thrombogenesis |
| 02/17/2009 | CA2157143C Alkylbenzoylguanidine derivatives |
| 02/15/2009 | CA2628900A1 Monoclonal antibodies against .beta.3 integrins |
| 02/12/2009 | WO2009020189A1 Anti-hypertensive agent |
| 02/12/2009 | WO2009020140A1 Adamantylurea derivative |
| 02/12/2009 | WO2009020137A1 Aminopyrazole amide derivative |
| 02/12/2009 | WO2009019303A2 A process for the preparation or purification of olmesartan medoxomil |
| 02/12/2009 | WO2009019202A1 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 02/12/2009 | WO2009019199A1 Crystalline teglicar |
| 02/12/2009 | WO2009018807A1 Oxazolidinones as factor xa inhibitors, methods for the production thereof, and use thereof in therapy |
| 02/12/2009 | WO2009018662A1 Renin inhibitors |
| 02/12/2009 | WO2009000909A8 Salts of perindopril |
| 02/12/2009 | WO2008140863A3 Local field stimulation for cell training of a biological pacemaker |
| 02/12/2009 | WO2008073865A3 Method of preventing or treating myocardial ischemia |
| 02/12/2009 | WO2008008024A3 Polymorphic forms of spirapril hydrochloride |
| 02/12/2009 | US20090044299 Artichoke hybrid named 'PS-H2015' |
| 02/12/2009 | US20090043379 Drug delivery systems for the prevention and treatment of vascular diseases |
| 02/12/2009 | US20090043378 Biocompatible Polymer System for Extended Drug Release |
| 02/12/2009 | US20090042979 Novel Statin Pharmaceutical Compositions and Related Methods of Treatment |
| 02/12/2009 | US20090042953 IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES |
| 02/12/2009 | US20090042951 Blood Pressure Reduction in Salt-Sensitive Hypertension |
| 02/12/2009 | US20090042944 Potassium Channel Inhibitors |
| 02/12/2009 | US20090042933 Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor |
| 02/12/2009 | US20090042931 Tricyclic Angiotensin II Agonists |
| 02/12/2009 | US20090042926 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 02/12/2009 | US20090042916 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
| 02/12/2009 | US20090042911 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/12/2009 | US20090042892 Cetp Inhibitors |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090042849 Phosphorylation of 5-lipoxygenase at ser523 and uses thereof |
| 02/12/2009 | US20090042842 Analogues of cilostazol |
| 02/12/2009 | US20090042809 Blood Pressure Lowering Protein Hydrolysates |
| 02/12/2009 | US20090042807 By reducing macrophage NO production through administration of one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides; inhibition of neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042795 Cardiac stem cell proliferation proteins, fragments thereof and methods of modulating stem cell proliferation and differentiation |
| 02/12/2009 | US20090042780 Modified TGF-Beta Superfamily Polypeptides and Related Methods |
| 02/12/2009 | US20090042772 Compounds and methods of treating insulin resistance and cardiomyopathy |
| 02/12/2009 | US20090041878 Extracts of passion fruit and uses therof |
| 02/12/2009 | US20090041870 Annatto Extract Compositions Including Tocotrienols and Tocopherols and Methods of Use |
| 02/12/2009 | US20090041841 Controlled release tablet formulations for the prevention of arrhythmias |
| 02/12/2009 | US20090041827 Therapeutic Microfoam |
| 02/12/2009 | US20090041766 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/12/2009 | US20090041752 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/12/2009 | US20090041745 Modulators of paraptosis and related methods |
| 02/12/2009 | US20090041739 Method for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of inflammatory agents in mammalian cells |
| 02/12/2009 | US20090041735 CD34 Stem cell-related methods and compositions |
| 02/12/2009 | CA2707334A1 A process for the preparation or purification of olmesartan medoxomil |
| 02/12/2009 | CA2695666A1 Anti-hypertensive agent |
| 02/12/2009 | CA2695461A1 Renin inhibitors |
| 02/12/2009 | CA2695437A1 Aminopyrazole amide derivative |
| 02/12/2009 | CA2695405A1 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 02/12/2009 | CA2693237A1 Composition and method for treatment of reperfusion injury and tissue damage |
| 02/11/2009 | EP2022790A1 A process for the preparation or purification of olmesartan medoxomil |
| 02/11/2009 | EP2022782A1 Process for production of optically active piperidine compound |
| 02/11/2009 | EP2022505A2 GLP-1, exendin-4, peptide analogs and uses thereof |
| 02/11/2009 | EP2022504A1 Ointment for the treatment of haemorrhoids |
| 02/11/2009 | EP2022495A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 02/11/2009 | EP2021338A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof |